TIL
Instil Bio Inc.
NASDAQ: TIL · HEALTHCARE · BIOTECHNOLOGY
$7.85
-2.85% today
Updated 2026-04-29
Market cap
$54.80M
P/E ratio
—
P/S ratio
54,248.82x
EPS (TTM)
$-10.70
Dividend yield
—
52W range
$6 – $43
Volume
0.0M
Instil Bio Inc. (TIL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.29M | $-29.62M | $-122.14M | $-180.16M | $-82.03M | $-55.70M | $-36.62M |
| Capital expenditures | $760000.00 | $50.82M | $57.83M | $84.59M | $20.66M | $10.00M | $10.00M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $293000.00 | $1.71M | $26.20M | $30.44M | $18.17M | $17.26M | $8.69M |
| Free cash flow | $-6.05M | $-80.43M | $-179.97M | $-264.75M | $-102.69M | $-65.70M | $-46.62M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-203.37M | — | — | — | — |